A comparison of high versus low dose recombinant human erythropoietin versus blood transfusion in the management of anaemia of prematurity in a developing country

Journal of Tropical Pediatrics

Volumn 48, Issue 4, 2002, Pages 227-233

  Avent, M ^a   Cory, B J ^b   Galpin, J ^a   Ballot, D E ^b   Cooper, P A ^b   Sherman, G ^a   Davies, V A ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

IRON DERIVATIVE; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; APGAR SCORE; ARTICLE; BIRTH WEIGHT; BLOOD TRANSFUSION; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DEVELOPING COUNTRY; DOSE RESPONSE; DRUG EFFICACY; ERYTHROCYTE; GESTATIONAL AGE; HEMATOCRIT; HEMATOLOGICAL PARAMETERS; HUMAN; INFANT; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NECROTIZING ENTEROCOLITIS; PATIENT CARE; PERINATAL PERIOD; PHLEBOTOMY; PREMATURITY; RANDOMIZATION;

ANEMIA, NEONATAL; CHI-SQUARE DISTRIBUTION; DEVELOPING COUNTRIES; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROCYTE TRANSFUSION; ERYTHROPOIETIN, RECOMBINANT; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INJECTIONS, SUBCUTANEOUS; MALE; PROBABILITY; REFERENCE VALUES; SOUTH AFRICA; TREATMENT OUTCOME;

EID: 0036053150     PISSN: 01426338     EISSN: None     Source Type: Journal    
DOI: 10.1093/tropej/48.4.227     Document Type: Article

References (19)

1. Effects of recombinant human erythropoietin in infants with the anemia of prematurity: A pilot study
2. Recombinant human erythropoietin in the anemia of prematurity: Results of a placebo-controlled pilot study
3. Efficacy and safety of recombinant human erythropoietin to prevent the anaemias of prematurity - European randomized multicenter trial
4. Erythropoietin to prevent and treat the anemia of prematurity
5. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants
6. Efficacy and cost analysis of treating very low birth weight infants with erythropoieten during their first two weeks of life: A randomized, placebo-controlled trial
7. Recombinant human erythropoietin in the treatment of the anemia of prematurity: Results of a double-blind, placebo-controlled study
8. High- versus low-dose erythropoietin in extremely low birth weight infants
9. Recombinant human erythropoietin stimulates eythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants
10. A cost analysis comparing erythropoietin and red cell transfusions in the treatment of anemia of prematurity
11. Optimizing the approach to anemia in the preterm infant: Is there a role for erythropoietin therapy?
12. Anaemia of prematurity
13. Factors related to transfusion in very low birth weight infants treated with erythropoietin
14. Follow-up of very low birth weight infants after erythropoietin treatment to prevent anemia of prematurity
15. Comparison between two and five doses a week of recombinant human erythropoietin for anemia of prematurity: A randomized trial
16. Postnatal changes in erythropoietin levels in untransfused premature infants
17. Serum erythropoietin levels during infancy: Associations with erythropoiesis
18. Effect of recombinant human erythropoiten on the switchover from fetal to adult hemoglobin synthesis in preterm infants
19. Double blind trial of recombinant human erythropoietin in preterm infants